Ticker

No recent analyst price targets found for AVCNF.

Latest News for AVCNF

ThreeD Capital Inc. Issues Early Warning Report in Connection with Disposition of Securities of Avicanna Inc.

TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD”) (CSE:IDK / OTCQX:IDKFF) a Canadian based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that through a series of transactions ending in recent weeks (the “Dispositions”), ThreeD disposed of ownership and control of an aggregate of 977,000 common…

GlobeNewsWire • Apr 7, 2026
Avicanna Announces Changes to its Board of Directors

TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announces effective Thursday April 1, 2026 the resignation of John McVicar and pleased to announce the appointment of Mr. Ozgur Kilic to the Board of…

GlobeNewsWire • Apr 6, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for AVCNF.

No Senate trades found for AVCNF.

No House trades found for AVCNF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top